Clinical Trial Update: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study of Debio 4228 is being conducted in participants with advanced prostate cancer and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Debio 4228

Snippet

Sponsor: Debiopharm International SA | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING